Case Report: The revelation of a new pathogenic variant in the POT1 gene in a patient with a pediatric high-grade glioma and a renal cell carcinoma - Top-Institutions - MDSpire

Case Report: The revelation of a new pathogenic variant in the POT1 gene in a patient with a pediatric high-grade glioma and a renal cell carcinoma

  • By

  • Selene Cipri

  • Antonella Cacchione

  • Annalisa Serra

  • Giada Del Baldo

  • Evelina Miele

  • Lucia Pedace

  • Sara Patrizi

  • Federica D’Antonio

  • Emanuele Agolini

  • Antonio Novelli

  • Alessandro Crocoli

  • Arianna Bertocchini

  • Andrea Carai

  • Sabina Barresi

  • Sabrina Rossi

  • Rita Alaggio

  • Francesca Diomedi Camassei

  • Giovanna Stefania Colafati

  • Luigi Boccuto

  • Angela Mastronuzzi

  • May 18, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Clinical Genetics

  • #2

    University of Texas MD Anderson Cancer Center
    University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Clinical Cancer Genetics

Original Source(s)

Case Report: The revelation of a new pathogenic variant in the POT1 gene in a patient with a pediatric high-grade glioma and a renal cell carcinoma

  • by Selene Cipri, Antonella Cacchione, Annalisa Serra, Giada Del Baldo, Evelina Miele, Lucia Pedace, Sara Patrizi, Federica D’Antonio, Emanuele Agolini, Antonio Novelli, Alessandro Crocoli, Arianna Bertocchini, Andrea Carai, Sabina Barresi, Sabrina Rossi, Rita Alaggio, Francesca Diomedi Camassei, Giovanna Stefania Colafati, Luigi Boccuto, Angela Mastronuzzi

  • May 18, 2026

Related Content

Management of toxicities from antibody – drug conjugates in breast cancer

Artificial intelligence for optimization of immunotherapy: current applications and transformative potential

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry